1)Nagle RE, Smith B, Williams DO. Familial atrial cardiomyopathy with heart block. Br Heart J 1972 ; 34 : 205.
2)Goette A, Kalman JM, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies : Definition, characterisation, and clinical implication. J Arrhythm 2016 ; 32 : 247-78.
3)Nattel S, Harada M. Atrial remodeling and atrial fibrillation : recent advances and translational perspectives. J Am Coll Cardiol 2014 ; 63 : 2335-45.
4)Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation : A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024 ; 149 : e1-e156.
5)Scherr D, Khairy P, Miyazaki S, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol 2015 ; 8 : 18-24.
6)Marrouche NF, Wazni O, McGann C, et al. Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation : The DECAAF II Randomized Clinical Trial. JAMA 2022 ; 327 : 2296-305.
7)Darbar D, Kannankeril PJ, Donahue BS, et al. Cardiac sodium channel(SCN5A)variants associated with atrial fibrillation. Circulation 2008 ; 117 : 1927-35.
8)Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003 ; 299 : 251-4.
9)Morita H, Kusano-Fukushima K, Nagase S, Fujimoto Y, Hisamatsu K, Fujio H, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002 ; 40 : 1437-44.
10)Marcoux E, Sosnowski D, Ninni S, et al. Genetic Atrial Cardiomyopathies : Common Features, Specific Differences, and Broader Relevance to Understanding Atrial Cardiomyopathy. Circ Arrhythm Electrophysiol 2023 ; 16 : 675-98.
11)Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999 ; 341 : 1715-24.
-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation : an analysis of the J-RHYTHM Registry. Circ J 2014 ; 78 : 1593-9.
13)Gibson DN, Di Biase L, Mohanty P, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation : clinical characterization, prevalence, and predictors. Heart Rhythm 2011 ; 8 : 1364-71.
14)Pilote L, Hüttner I, Marpole D, et al. Stiff left atrial syndrome. Can J Cardiol 1988 ; 4 : 255-7.
15)Müller H, Noble S, Keller PF, et al. Biatrial anatomical reverse remodelling after radiofrequency catheter ablation for atrial fibrillation : evidence from real-time three-dimensional echocardiography. Europace 2008 ; 10 : 1073-8.
16)Wylie JV, Jr., Peters DC, Essebag V, et al. Left atrial function and scar after catheter ablation of atrial fibrillation. Heart Rhythm 2008 ; 5 : 656-62.
17)Choi JI, Park SM, Park JS, et al. Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation. Circ J 2008 ; 72 : 2051-7.
18)Witt CM, Fenstad ER, Cha YM, et al. Increase in pulmonary arterial pressure after atrial fibrillation ablation : incidence and associated findings. J Interv Card Electrophysiol 2014 ; 40 : 47-52.
19)Ad N, Tian YY, Verbalis J, et al. The effect of the maze procedure on the secretion of arginine-vasopressin and aldosterone. J Thorac Cardiovasc Surg 2003 ; 126 : 1095-100.
20)Wong GR, Lau DH, Baillie TJ, et al. Novel use of sildenafil in the management of pulmonary hypertension due to post-catheter ablation ‘stiff left atrial syndrome'. Int J Cardiol 2015 ; 181 : 55-6.